1.
Clin Case Rep
; 9(7): e04459, 2021 Jul.
Article
in English
| MEDLINE | ID: covidwho-1300375
ABSTRACT
COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.